baber/WOPTO huggingface dataset:
Patent AU-2016383059-A1 (AU)
Title: Stable inoculant compositions and methods for producing same
Inventor: GREENSHIELDS DAVE
IPC: A01N63/36
Filed: 2016-12-20
Abstract: The present disclosure provides aqueous inoculant compositions and methods for enhancing the survival and/or stability of microbial spores in an inoculant composition. In some embodiments, aqueous inoculant compositions of the present disclosure comprise microbial spores, one or more dispersants, one or more protectants, one or more aqueous additives and a non-aqueous liquid carrier.
Patent AU-2016424720-A1 (AU)
Title: Aqueous polymer composition
Inventor: HU YUEHAN
IPC: C09D201/06
Filed: 2016-09-29
Abstract: An aqueous polymer composition and a coating composition comprising the aqueous polymer composition and affording coatings with improved efflorescence properties.
Patent WO-2018107200-A1 (WO)
Title: Inhibiteurs d'héparanase et leur utilisation
Inventor: NELMS KEATS
IPC: C07D417/12
Filed: 2017-12-13
Abstract: L'invention concerne des composés de quinazoline fonctionnalisés, des compositions pharmaceutiques comprenant de tels composés, et l'utilisation de tels composés en tant qu'inhibiteurs d'héparanase pour le traitement de maladies ou d'états pathologiques liés à l'activité de l'héparanase.
Patent WO-2018064715-A1 (WO)
Inventor: AYTON SCOTT
IPC: A61B5/055
Filed: 2017-10-02
Abstract: The present invention relates to assessing, predicting or diagnosing cognitive deterioration in a patient with amyloid deposition in the brain as measured by magnetic susceptibility and preferably using QSM and/or transverse relaxation as an indicator of the rate of decline in cognitive capacity. Patients can be stratified based on the magnetic susceptibility preferably as measured using QSM and/or transverse relaxation which predicts the trajectory of cognitive decline in amyloid positive subjects.
Patent AU-2017200289-A1 (AU)
Title: Method for producing C4 oxygenates by fermentation using high oxidation state sulfur
Inventor: TOBEY RICHARD E
IPC: C12P7/16
Filed: 2017-01-17
Abstract: H:\rbr\Interoven\NRPortbl\DCC\RBR\12741066 L.docx-17/01/2017 The invention relates to improvements in the production of butanol and butyrate by microbial fermentation, particularly to production of alcohols by microbial fermentation of a substrate comprising CO and the addition of an inorganic sulfur additive. It more particularly relates to the provision of an inorganic organic sulfur source to a fermentation system such that one or more micro-organisms convert a substrate comprising CO to butanol. In one aspect the invention uses a sulfur additive comprising inorganic sulfur compounds having a +2 to a +4 sulfur oxidation state that produces sulfur oxoanions and hydrosulfur oxoanions in an aqueous fermentation medium.
Patent AU-2017201383-A1 (AU)
Title: Pool cleaner with detachable scrubber assembly
Inventor: GOPALAN SURESH
IPC: E04H4/16
Filed: 2017-02-28
Abstract: POOL CLEANER WITH DETACHABLE SCRUBBER ASSEMBLY There is disclosed a pool cleaner (10) comprising: a chassis (48) including at least one front axle; at least one front wheel assembly (38) rotatable about the at least one front axle (34), the at least one front wheel assembly (28) including inner gear teeth (36); a spur gear (109) engaged with the inner teeth (36) of the at least one front wheel assembly (28) so that rotation of the at least one front wheel assembly (28) causes rotation of the spur gear (109); and a scrubber assembly (66) removably coupled to the chassis and including a center shaft (100) and a pinion gear (102), wherein the the pinion gear (102) is engagable with the spur gear (109) when coupled to the chassis so that rotation of the spur gear (109) causes rotation of the scrubber assembly (66), the spur gear (109) and the pinion gear (102) being aligned radially off-center from the center shaft (100) when engaged with the scrubber assembly (66).
Patent AU-2017204035-A1 (AU)
Title: Container for surgical instruments and system including same
Inventor: SCOTT KURT A
IPC: A61J1/00
Filed: 2017-06-15
Abstract: A system for use in an orthopaedic surgical procedure including a container for orthopaedic surgical instruments. The container includes a first shell, and a second shell configured to be coupled to the first shell to define a chamber therein. The second shell is configured to be coupled to the first shell in a plurality of orientations including a first orientation in which fluid is permitted to advance into and out of the chamber, and a second orientation in fluid is prevented from advancing into and out of the chamber. if iS 'I Ca t)
Patent AU-2017216466-A1 (AU)
Title: Fluidic capillary chip for regulating drug flow rates of infusion pumps
Inventor: BORK TORALF
IPC: A61M5/142
Filed: 2017-08-15
Abstract: An erosion-resistant capillary chip for use with in an infusion pump that is made from a silicon substrate having a first surface that includes a micro groove etched therein and a glass plate laminated to the first surface. The glass plate covers the micro groove so that a micro fluid conduit is created. The glass plate includes an inlet bore that connects with the micro fluid conduit and the silicon substrate includes an outlet bore that connects with the micro fluid conduit so that a drug solution entering the inlet bore from the infusion pump may pass through the micro fluid conduit at a restricted flow rate to the outlet bore and thereafter to a target site of a patient. The micro groove includes a passivation layer made from silicon nitride or silicon carbide that protects the micro groove against erosion from passing fluids having high basic or high acidic pH levels. A method for making the capillary chip is disclosed, as well as an infusion pump incorporating the improved capillary chip.
Patent AU-2017219121-A1 (AU)
Title: Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor Antagonists
Inventor: PAVLIV LEO
IPC: C12N5/16
Filed: 2017-08-28
Abstract: The present invention is directed to methods of treating hepatorenal syndrome by administration of a therapeutically effective amount of a thromboxane. A2 receptor antagonist to a patient in need thereof. The present invention is also directed to methods of treating hepatic encephalopathy and cerebral edema by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist to a patient in need thereof,
Patent AU-2017222407-A1 (AU)
Title: Accelerated pavement testing
Inventor: RUST FREDERIK CHRISTOFFEL
IPC: G01N3/10
Filed: 2017-01-16
Abstract: A method of testing pavement includes repeatedly simulating wheel loading on the pavement by repeatedly applying a plurality of discreet forces with a downwards component, in series and one after the other, to an upper surface of a test strip of the pavement thereby to simulate a load exerted by a travelling wheel and hence subjecting the pavement to accelerated testing. Also provided is an accelerated pavement testing device (10) which includes a carrier (12) and an array of actuators (16) carried by the carrier (12) and configured each rapidly and repeatedly to apply a discrete force with a downwards component to an upper surface of a test strip of pavement. Each actuator (16) is associated with at least one force transfer element or sole (22) configured in use to transfer said discreet force from the actuator (16) to pavement being tested thereby to simulate a load exerted by a travelling wheel to the test strip of pavement and hence to subject the pavement to accelerated testing.
Patent AU-2017225070-A1 (AU)
Title: Impaired energy processing disorders and mitochondrial deficiency
Inventor: SHCHEPINOV MIKHAIL SERGEEVICH
IPC: A61K31/202
Filed: 2017-09-07
Abstract: Some aspects of the invention provide for a method of treating Impaired Energy Processing Disorders and Mitochondrial Deficiencies using polyunsaturated fatty acids which are modified in certain positions to attenuate oxidative damage by Reactive Oxygen Species (ROS) and/or suppress the rate of formation of reactive products and toxic compounds.
Patent AU-2017229488-A1 (AU)
Title: Method and system for characterizing mouth-associated conditions
Inventor: APTE ZACHARY
IPC: G06F19/00
Filed: 2017-03-07
Abstract: Embodiments of a system and method for characterizing a mouth-associated condition in relation to a user can include one or more of: a handling network operable to collect containers including material from a set of users, the handling network including a sequencing system operable to determine microorganism sequences from sequencing the material; a microbiome characterization system operable to determine microbiome composition data and microbiome functional diversity data based on the microorganism sequences, collect supplementary data associated with the mouth-associated condition for the set of users, and transform the supplementary data and features extracted from the microbiome composition data and the microbiome functional diversity data into a characterization model for the mouth-associated condition; and/or a therapy system operable to promote a treatment to the user based on characterizing the user with the characterization model in relation to the mouth-associated condition.
Patent AU-2017232180-A1 (AU)
Title: Systems and methods for controlling flushing apparatus and related interfaces
Inventor: TAYLOR THOMAS M
IPC: F17D1/00
Filed: 2017-09-22
Abstract: SYSTEMS AND METHODS FOR CONTROLLING FLUSHING APPARATUS AND RELATED INTERFACES PRIORITY Abstract The invention concerns a method of maintaining water quality in a water distribution system using a flushing and sampling station, comprising: flushing the water distribution system in accordance with a plurality of flushing programs stored in a memory of the flushing and sampling station when it is determined that the flushing program is active; determining whether an alarm has been triggered; logging a time of the alarm when it is determined that an alarm has been triggered; determining a state change of the flow control valve of the flushing and sampling station; logging a time and date of the state change of the flow control valve when it is determined that a state change of the flow control valve has occurred; communicating with a remote location by responding to a data request from the remote location; and displaying an operational status of the flushing and sampling station. I\- L co C-0 ~ThL co
Patent AU-2017237186-A1 (AU)
Title: Process for the preparation of PEGylated drug-linkers and intermediates thereof
Inventor: MAO YUNYU
IPC: C07K16/28
Filed: 2017-03-24
Abstract: The present invention provides improved processes for the preparation of auristatin drug-linkers with a PEG unit, as well as intermediates thereof.
Patent AU-2017254803-A1 (AU)
Title: Virtual and augmented reality systems and methods
Inventor: SCHOWENGERDT BRIAN
IPC: H04J14/00
Filed: 2017-10-30
Abstract: Configurations are disclosed for presenting virtual reality and augmented reality experiences to users. The system may comprise an image-generating source to provide one or more frames of image data in a time-sequential manner, a light modulator configured to transmit light associated with the one or more frames of image data, a substrate to direct image information to a user's eye, wherein the substrate houses a plurality of reflectors, a first reflector of the plurality of reflectors to reflect transmitted light associated with a first frame of image data at a first angle to the user's eye, and a second reflector to reflect transmitted light associated with a second frame of the image data at a second angle to the user's eye.
Patent AU-2017262404-A1 (AU)
Title: Hearing protector and data transmission device
Inventor: GUSTAVSSON ANDREAS
IPC: A61F11/14
Filed: 2017-05-05
Abstract: A hearing protector device (9) comprising a controller (11), a memory (14), and a receiver (12) is provided. The controller (11) is configured to be connected to the memory (14), the receiver (12) and an at least one user-notifying device (31) adapted to notify a hearing protector user. The hearing protector device (9) is configured to receive at least one data transmission signal from a data transmission device (20); storing at least one signal parameter; and comparing said data transmission signal to the at least one stored signal parameter. The at least one stored signal parameter is associated with at least one suitable notification; wherein the user-notifying device (31) is configured to, when the signal from the data transmission device (20) matches the signal parameter, present the at least one notification associated to the signal parameter to the hearing protector user. A data transmission device (20) comprising a processor (21) configured to be connected to an external signal receiver (22) and a data device transmitter (23) is also provided, wherein the data transmission device (20) is configured to receive at least one external signal from an external source (40) and transmit a data transmission signal configured to be received by at least one hearing protector device (9).
Patent AU-2017264267-A1 (AU)
Title: A composition comprising a lactic acid bacteria for preventing and treating vaginosis and the use thereof
Inventor: CHOI WON SEOG
IPC: A61K35/747
Filed: 2017-04-26
Abstract: The present invention relates to a composition comprising an inventive combination of salt, sugar and lactic acid bacteria as an active ingredient to treat or prevent vaginosis. The inventive composition showed potent antibacterial activity through various experiments, for example, (1) the indirect inhibitory activity test from the growth of vaginosis causing bacteria by determining the change of pH and lactic acid level (Experimental example 1); (2) the direct inhibitory activity test from the growth of vaginosis causing bacteria by determining the susceptibility of test sample (Experimental example 2); (3) brief clinical tests, and finally confirmed that the combination showed potent antibacterial activity in the test. Accordingly, the inventive combination may be useful to alleviate, treat or prevent vaginosis in the form of a pharmaceutical composition, health functional food, food additive, topical composition, and detergent composition.
Patent AU-2017272177-A1 (AU)
Title: Methods And Compositions For Modulating Angiogenesis And Vasculogenesis
Inventor: DAO MONIQUE
IPC: A61K35/28
Filed: 2017-12-05
Abstract: Disclosed herein are methods and compositions for stimulating angiogenesis, using cells descended from marrow adherent stromal cells that have been transfected with sequences encoding a Notch intracellular domain. Applications of these methods and compositions include 5 treatment of ischemic disorders such as stroke.
Patent AU-2017305029-A1 (AU)
Title: User terminal and wireless communication method
Inventor: SAITO KEISUKE
IPC: H04W72/04
Filed: 2017-08-02
Abstract: A user terminal receives a downstream link data signal, a demodulation reference signal for demodulating the downstream link data signal, and a downstream link signal including a downstream link control signal; calculates a channel estimation value using the demodulation reference signal; demodulates the downstream link data signal using the channel estimation value; and demodulates the downstream link control signal using the channel estimation value calculated from the demodulation reference signal mapped to a symbol before a symbol to which the downstream link control signal is mapped in a sub-frame.
Patent AU-2017326989-A1 (AU)
Title: Cardiovascular assist system that quantifies heart function and facilitates heart recovery
Inventor: EDELMAN ELAZER
IPC: A61M60/554
Filed: 2017-09-19
Abstract: The systems, devices, and methods presented herein use a heart pump to obtain measurements of cardiovascular function. The heart pumps described herein can operate in parallel with and unload the heart. The system can quantify the functioning of the native heart by measuring certain parameters/signals such as pressure or motor current, then calculate and display one or more metrics of cardiovascular function. These metrics, such as left ventricular end diastolic pressure (LVEDP), left ventricular pressure, and contractility, provide valuable information to a user regarding a patient's state of heart function and recovery.
Patent AU-2017371122-A1 (AU)
Title: Inhalation device with integrated electronics module
Inventor: YANG DONG
IPC: A61M15/00
Filed: 2017-12-05
Abstract: A device (400) for delivering medication to a user includes a circular or elliptical body (410) that includes a mouthpiece (420), a flexible strip (401) of medication, a lever (424), and a mouthpiece cover (491), where the mouthpiece cover is rotatable about the body. An electronics module (120) includes a communication circuit (134), a power supply (126), a sensor system (128), and a switch. The lever is configured to actuate the switch when the lever is moved from a closed position to an open position. The lever is further configured to advance a dose of medication on the flexible strip when moved from the closed position to the open position. The switch switches the electronics module from an off state to an active state when the lever is actuated for a first time by a user. The electronics module is configured to not return to the off state thereafter.
Patent AU-2017374924-A1 (AU)
Title: Filaments for use as a support material in fused deposition modeling
Inventor: KOPPING JORDAN THOMAS
IPC: B29C64/00
Filed: 2017-12-06
Abstract: The present invention relates to the use of a filament comprising a core material (CM) comprising a ceramic material precursor (CMP)and the core material (CM) is coated with a layer of shell material (SM) comprising a thermoplastic polymer as a support material in a fused filament fabrication process. Further, the invention relates to three-dimensional objects and a process for the preparation thereof.
Patent AU-2017376836-A1 (AU)
Title: Composition and uses thereof
Inventor: DREDGE KEITH
IPC: A61K31/702
Filed: 2017-12-15
Abstract: The present invention relates,
Patent AU-2017378839-A1 (AU)
Title: Drug eluting stent and method of use of the same for enabling restoration of functional endothelial cell layers
Inventor: SUN JIANHUA
IPC: B05D3/10
Filed: 2017-10-30
Abstract: Drug eluting stents，methods of making， using， and verifying long-term stability of the drug eluting stents，and methods for predicting long term stent efficacy and patient safety after implantation of a drug eluting stent are disclosured．In one embodiment，a drug eluting stent may include a stent framework；a drug-containing layer；a drug embedded in the drug-containing layer；and a biocompatible base layer disposed over the stent framework and supporting the drug-containing layer．The drug－containing layer may have an uneven coating thickness．In addition or in alternative，the drug-containing layer may be configured to significantly dissolve／dissipate／disappear between 45 days and 60 days after stent implantation．Stents may reduce，minimize，or eliminate patient risks associated with the implantation of a stent，including，for example，restenosis，thrombosis，and／or MACE．
Patent AU-2017382243-A1 (AU)
Title: Compositions and methods for modulating the immune system
Inventor: NOONAN KIMBERLY A
IPC: A61K35/13
Filed: 2017-12-21
Abstract: Embodiments provided for herein relate to compositions and methods related to chimeric proteins that can be used to modulate a subject's immune system and, for example, treat cancer.
Patent AU-2017382388-A1 (AU)
Title: Method and system for providing artificial intelligence analytic (AIA) services for performance prediction
Inventor: TONG RICHARD CHIA TSING
IPC: B60W50/00
Filed: 2017-12-22
Abstract: One embodiment of the present invention predicts a vehicular event relating to machinal performance using information obtained from interior and exterior sensors, vehicle onboard computer ("VOC"), and cloud data. The process of predication is able to activate interior and exterior sensors mounted on a vehicle operated by a driver for obtaining current data relating to external surroundings, interior settings, and internal mechanical conditions of the vehicle. After forwarding the current data to VOC to generate a current vehicle status representing real-time vehicle performance in accordance with the current data, retrieving a historical data associated with the vehicle including mechanical condition is retrieved. In one aspect, a normal condition signal is issued when the current vehicle status does not satisfy with the optimal condition based on the historical data. Alternatively, a race car condition is issued when the current vehicle status meets with the optimal condition.
Patent AU-2017387781-A1 (AU)
Title: Automatic control of wearable display device based on external conditions
Inventor: POWDERLY JAMES M
IPC: G16C10/00
Filed: 2017-11-17
Abstract: Embodiments of a wearable device can include a head-mounted display (HMD) which can be configured to display virtual content. While the user is interacting with visual or audible virtual content, the user of the wearable may encounter a triggering event such as, for example, an emergency condition or an unsafe condition, detecting one or more triggering objects in an environment, or determining characteristics of the user's environment (e.g., home or office). Embodiments of the wearable device can automatically detect the triggering event and automatically control the HMD to deemphasize, block, or stop displaying the virtual content. The HMD may include a button that can be actuated by the user to manually deemphasize, block, or stop displaying the virtual content.
Patent AU-2018200152-A1 (AU)
Title: Vascular access device and guiding portion
Inventor: PEH RUEY FENG
IPC: A61M5/158
Filed: 2018-01-08
Abstract: Abstract A vascular access system comprising: a needle having a tip portion; and a rigid sheath arranged around and at least substantially along a longitudinal axis of the needle; and a guiding portion configured to be placed at least at a subcutaneous tissue above a blood vessel and configured to receive and guide a needle to reach the blood vessel, the guiding portion comprising a channel portion comprising an inlet and an outlet; wherein the rigid sheath is configured to provide strength to the tip portion to penetrate at least one of the subcutaneous tissue layer and a skin layer over the subcutaneous tissue layer as the tip portion extends out from the rigid sheath; wherein the needle conforms to the channel portion as the distance between the tip portion and the rigid sheath increases; and wherein the outlet comprises a constriction which is configured to cause the needle to regain push force to penetrate the blood vessel.
Patent AU-2018203204-A1 (AU)
Title: Method, device, and system for scheduling transmission of a status update in a time division multiple access (tdma) communication system
Inventor: YANG YUNHAI
IPC: H04W74/00
Filed: 2018-05-08
Abstract: A method, device, and system for scheduling a status update in a time division multiple access (TDMA) communication system. One method includes transmitting, with a call controller, scheduling information to the each of the plurality of communication devices 5 via an outbound time slot associated with a control channel of a local common TDMA channel to schedule the each of the plurality of communication devices to transmit the status data in a pre-determined sequence. The method also includes receiving the status data from at least one of the plurality of communication devices in the pre-determined sequence. -17 -- -- ------- -------- --- --- ~ 'K ----------------------------------------------------
Patent AU-2018211536-A1 (AU)
Title: Compounds reducing malodour perception and the use thereof
Inventor: CHATELAIN PIERRE
IPC: C07C255/57
Filed: 2018-01-30
Abstract: The present invention relates to new malodour-counteracting agents of formula (I) or stereoisomers thereof, particularly useful in blocking the olfactory perception of androstenone, Formula (I), wherein R